Identification and characterization of mouse metastasis-suppressor KiSS1 and its G-protein-coupled receptor

Lewis Joe Stafford1, Chunzhi Xia, Wenbin Ma

  • 1Center for Cancer Biology and Nutrition, Alkek Institute of Biosciences and Technology, Texas A&M University System Health Science Center, Houston, Texas 77030, USA.

Cancer Research
|October 3, 2002
PubMed

Insights

The KiSS1 peptide and its receptor inhibit tumor metastasis by blocking cell growth and migration. This study identifies mouse versions and their signaling pathways, revealing a G-protein-coupled phospholipase C mechanism.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • G-protein-coupled receptors (GPCRs) regulate critical cellular functions including growth, proliferation, and migration.
  • The KiSS1 gene acts as a metastasis suppressor, inhibiting the spread of human melanomas and breast carcinomas.
  • The KiSS1 gene encodes a peptide ligand for a novel GPCR, but its antimetastatic mechanism remains unclear.

Purpose of the Study:

  • To identify mouse homologues of the KiSS1 peptide and its cognate GPCR.
  • To characterize the signaling pathways activated by the KiSS1 receptor.
  • To elucidate the mechanism underlying KiSS1's antimetastatic actions.

Main Methods:

  • Comparative sequence analysis of human and mouse KiSS1 proteins and peptides.
  • Identification and characterization of mouse KiSS1 receptor homologues.
  • Investigation of signaling pathways, including G-protein-activated phospholipase C (PLC-beta) and Ca2+ signaling, upon receptor activation.

Main Results:

  • Mouse and human KiSS1 active peptides are highly conserved (10 amino acids), differing by only one residue.
  • KiSS1 peptide activation of its receptor triggers the Galphaq-mediated PLC-beta signaling pathway.
  • Activation of the KiSS1 receptor demonstrably inhibits cancer cell proliferation and migration.

Conclusions:

  • The study elucidates the molecular mechanism of KiSS1's antimetastatic function through GPCR signaling.
  • The conserved KiSS1-GPCR pathway offers potential therapeutic targets for inhibiting cancer metastasis.
  • This research provides insights into the regulation of cell growth, migration, and metastasis via specific GPCR pathways.